Not Tagged
Castle Biosciences
[]
late-breaking data presented at the 2023 aad annual meeting demonstrates improved accuracy of decisiondx -scc in predicting metastatic risk over traditional staging systems in independent, multi-center cohort study $cstl 
Real-Time News, Market Data and Stock Quotes for Biotech, Pharma, and Healthcare Stocks